Morten Herholdt
Stock Analyst at HSBC
(3.44)
# 2,354
Out of 4,966 analysts
39
Total ratings
69.2%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Reiterated: Sell | $157 → $175 | $217.15 | -19.41% | 8 | Sep 10, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $155 → $175 | $143.72 | +21.76% | 7 | Sep 10, 2026 | |
| JNJ Johnson & Johnson | Reiterated: Buy | $290 → $320 | $265.58 | +20.49% | 10 | Sep 10, 2026 | |
| AMGN Amgen | Downgraded: Hold | $425 | $377.35 | +12.63% | 6 | Sep 9, 2026 | |
| ZTS Zoetis | Reiterated: Buy | $230 | $72.97 | n/a | 2 | Feb 19, 2024 | |
| UNH UnitedHealth Group | Downgraded: Sell | $540 → $480 | $379.09 | n/a | 2 | Dec 18, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiated Coverage: Buy | $12 | $1.40 | n/a | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiated Coverage: Buy | $260 | $258.17 | n/a | 1 | Sep 6, 2023 | |
| LH Labcorp Holdings | Initiated Coverage: Hold | $210 | $311.54 | n/a | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiated Coverage: Hold | $52 | $78.18 | n/a | 1 | Sep 6, 2023 |
Biogen
Sep 10, 2026
Reiterated: Sell
Price Target: $157 → $175
Current: $217.15
Upside: -19.41%
Gilead Sciences
Sep 10, 2026
Reiterated: Buy
Price Target: $155 → $175
Current: $143.72
Upside: +21.76%
Johnson & Johnson
Sep 10, 2026
Reiterated: Buy
Price Target: $290 → $320
Current: $265.58
Upside: +20.49%
Amgen
Sep 9, 2026
Downgraded: Hold
Price Target: $425
Current: $377.35
Upside: +12.63%
Zoetis
Feb 19, 2024
Reiterated: Buy
Price Target: $230
Current: $72.97
Upside: n/a
UnitedHealth Group
Dec 18, 2023
Downgraded: Sell
Price Target: $540 → $480
Current: $379.09
Upside: n/a
Actinium Pharmaceuticals
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $12
Current: $1.40
Upside: n/a
IQVIA Holdings
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $260
Current: $258.17
Upside: n/a
Labcorp Holdings
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $210
Current: $311.54
Upside: n/a
LivaNova
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $52
Current: $78.18
Upside: n/a